Immunovant, Inc. SEC filings IMVT

Immunovant, Inc. has 648 filings in SEC EDGAR's recent list, going back to Jan 23, 2019. Its latest annual report, Form ARS, was filed on Jul 22, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 3, 2026 (shareholder vote results). The company's fiscal year ends on March 31.

Form Description Filed Period
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
10-Q Quarterly report Feb 6, 2026 Dec 31, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
10-Q Quarterly report Feb 6, 2025 Dec 31, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
10-Q Quarterly report Feb 12, 2024 Dec 31, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
10-Q Quarterly report Feb 3, 2023 Dec 31, 2022
10-Q Quarterly report Nov 4, 2022 Sep 30, 2022
10-Q Quarterly report Aug 5, 2022 Jun 30, 2022
10-Q Quarterly report Feb 4, 2022 Dec 31, 2021
10-Q Quarterly report Nov 5, 2021 Sep 30, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
10-Q Quarterly report Feb 16, 2021 Dec 31, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
10-Q Quarterly report Feb 14, 2020 Dec 31, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
10-Q Quarterly report Jun 12, 2019 Mar 31, 2019

Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IMVT (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Large accelerated filer
SEC CIK
1764013
Former names
Health Sciences Acquisitions Corp (until Dec 20, 2019)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.